Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Aster Silicates IPO and Parabolic Drugs IPO.
Aster Silicates IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Parabolic Drugs IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Aster Silicates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Saffron Capital Advisors Private Limited | ICICI Securities Limited Spa Capital Advisors Ltd |
| Registrar | Sharepro Services Private Limited | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Aster Silicates IPO is up to ₹53.10 Cr whereas the issue size of the Parabolic Drugs IPO is up to ₹200.00 Cr. The final issue price of Aster Silicates IPO is ₹118.00 per share and of Parabolic Drugs IPO is ₹75.00 per share.
| Aster Silicates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹112.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹118.00 per share | ₹85.00 per share |
| Issue Price (Final) | ₹118.00 per share | ₹75.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 50 shares | 80 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 45,00,000 shares | 2,66,66,667 shares |
| Issue Size Total (Amount) | up to ₹53.10 Cr | up to ₹200.00 Cr |
Aster Silicates IPO opens on Jun 24, 2010, while Parabolic Drugs IPO opens on Jun 14, 2010. The closing date of Aster Silicates IPO and Parabolic Drugs IPO is Jun 28, 2010, and Jun 17, 2010, respectively.
| Aster Silicates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 24, 2010 | Jun 14, 2010 |
| Issue Close | Jun 28, 2010 | Jun 17, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Aster Silicates IPO P/E ratio is , as compared to Parabolic Drugs IPO P/E ratio of .
| Aster Silicates IPO | Parabolic Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 71.43% | 63.2% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 49.8% | 46.5% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 16.36%% | 6.21%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 14.18%% | 19.96%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aster Silicates IPO retail investors (RII) are offered 16,59,375 shares while in Parabolic Drugs IPO retail investors are offered 16,59,375 shares. Qualified institutional buyers (QIB) are offered 23,70,535 shares in Aster Silicates IPO and 1,30,83,333 shares in Parabolic Drugs IPO.
| Aster Silicates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 23,70,535 shares | 1,30,83,333 shares |
| NII | 7,11,161 shares | 39,25,000 shares |
| RII | 16,59,375 shares | 91,58,334 shares |
| Employee | 5,00,000 shares | |
| Others | ||
| Total | 47,41,071 shares | 2,66,66,667 shares |
Aster Silicates IPO subscribed 4.47x in total, whereas Parabolic Drugs IPO subscribed 1.04x.
| Aster Silicates IPO | Parabolic Drugs IPO | |
|---|---|---|
| QIB (times) | 0.01x | 1.48x |
| NII (times) | 12.46x | 1.20x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.41x | 0.40x |
| Employee (times) | 0.11x | |
| Other (times) | ||
| Total (times) | 4.47x | 1.04x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
